drugset / Trial / NCT04203186

A Clinical Trial to Evaluate Plasmodium Falciparum 7G8 and NF54 Challenge Strains (PfSPZ) in a Head-to-head Comparative Study - (ECG-CHMI)

NCT04203186 ↗

RandomizedParallel-groupTriple-blindDiagnostic

Summary

A comparison of Malaria events (symptoms and signs of malaria) experienced by subjects infected with PfSPZ Challenge (NF54) vs. PfSPZ Challenge (7G8).

Timeline

Start
2020-03
Primary completion
2021-06
Completion
2021-09

Outcome

Outcome not reported

Stopped (Business): “Funding was lost due to the COVID19 Pandemic”

Drugs

EvaluationDrugModalityDoseRoute
Comparator Atovaquone Small molecule — —
Comparator Proguanil Small molecule — —